Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote
It is approved only for short-term use (up to 12 weeks), which limits its utility for chronic weight management
Beginning his career at Lupin Laboratories, Raakesh has moved on to CFL as a frontline manager, followed by Morepen Laboratories
In patients with T1D without functioning beta cells and T2D with dysfunctional beta cells, exogenous insulin may be used as a replacement, yet the manner in which it is done is quite different
Hershman randomized women receiving adjuvant taxane chemotherapy for early breast cancer evenly to either oral ALC 1,000 mg three times daily or matching placebo, for 24 weeks
Chat starts with an AI agent but can connect you to a human